VERDE BIO HOLDINGS, INC.

APHD

VERDE BIO HOLDINGS, INC.

APHD

Insider Sentiment (TTM):

Last Purchase:2023-10-03Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:N/AInstitutional Shares Owned:N/AShares Outstanding:N/AInstitutional Ownership Pct.:N/A

Earnings Market Reaction:

Filing Date:2024-03-25Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Crude Petroleum & Natural Gas

CNX EOG OXY FANG EQT DVN

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31	2022-10-31	2022-07-31	2022-04-30	2022-01-31	2021-10-31	2021-07-31	2021-04-30	2021-01-31
Assets
Related Party	0	-	-	-	-	-	-	-	-	-	-	-	-
Series C Accrued Dividends	0	-	-	-	-	-	-	-	-	-	-	-	-
Cash	0	0	0	0	0	0	0	0	1	0	1	2	0
Accounts Receivable Related Parties Current	-	-	-	-	0	0	0	0	0	0	0	0	-
Assets Current
Assets Current	0	0	0	0	0	0	0	0	1	0	1	2	0
Prepaid Expense And Other Assets Current	-	0	0	0	0	0	0	0	0	0	0	0	-
Accounts Receivable Net Current	0	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expense Current	0	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Asset	-	0	0	0	0	0	0	0	0	0	0	0	-
Assets Noncurrent
Property Plant And Equipment Net	1	3	3	3	3	3	3	3	3	3	0	0	-
Oil And Gas Property Full Cost Method Net	1	1	1	1	1	2	2	2	2	2	5	1	0
Assets	2	4	4	4	4	5	5	5	5	5	6	3	0
Liabilities
Commitments And Contingencies	-	-	-	-	-	-	-	-	-	-	-	-	0
Notes Payable Current	-	-	-	-	-	-	-	-	-	-	-	0	0
Accounts Payable And Accrued Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0	0
Convertible Debt Current	-	-	-	-	-	-	0	0	0	0	0	0	1
Liabilities Current
Liabilities Current	-	-	-	2	2	2	2	1	1	0	0	0	-
Derivative Liabilities Current	-	-	-	-	-	-	-	0	0	0	0	0	1
Loans Payable	-	-	-	-	-	0	-	-	-	-	-	-	-
Convertible Notes Payable	-	0	0	0	0	-	-	0	-	-	-	-	-
Due To Related Parties Current	-	-	-	-	0	-	-	-	-	-	-	0	0
Operating Lease Liability Current	-	0	0	0	0	0	0	0	0	0	0	0	-
Operating Lease Liability Noncurrent	-	-	-	0	0	0	0	0	0	0	0	0	-
Convertible Notes Payable Current	0	-	-	-	-	-	-	-	-	-	-	-	-
Warrants And Rights Outstanding	1	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities	2	2	2	2	2	2	2	1	2	0	0	1	3
Temporary Equity Carrying Amount Attributable To P…	0	0	0	-	-	-	-	-	-	-	-	-	-
Preferred Stock Value	0	-	-	-	-	-	-	-	-	0	0	0	0
Common Stock Value	2	2	2	2	1	1	1	1	1	1	1	1	0
Common Stock Issuable
Stockholders Equity
Additional Paid In Capital	16	16	17	17	17	17	17	17	17	17	17	12	5
Stockholders Equity	0	2	2	2	3	3	3	4	4	5	6	3	-2
Retained Earnings Accumulated Deficit	-18	-17	-16	-16	-16	-15	-15	-14	-14	-13	-12	-11	-8
Liabilities And Stockholders Equity	2	4	4	4	4	5	5	5	5	5	6	3	0
Debt Instrument Unamortized Discount	-	-	-	-	-	-	-	-	-	-	-	0	0
Temporary Equity
Series C Preferred Stock	0	0	0	0	-0	0	0	0	0	-	-	0	-
Series A Preferred Stock	-0	0	1	1	0	0	1	1	0	0	1	1	0
Preferred Stock Shares Authorized	-	-	-	-	-	-	-	-	-	10	10	10	10
Preferred Stock Par Or Stated Value Per Share	-	0.001	0.001	-	-	0.001	0.001	-	0.001	0.001	0.001	0	0.001
Common Stock Shares Authorized	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000	100,000
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0	0.001	0.001	0.001	0	0.001	0.001	0.001	0	0.001
Common Stock Shares Issued	1,932	1,755	1,683	1,543	1,424	1,324	1,278	1,179	1,165	1,165	1,163	1,366	1,173
Shares Outstanding	1,932	1,755	1,683	1,543	1,424	1,324	1,278	1,179	1,165	1,165	1,163	1,366	1,173

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2024	0.00%	-99.72%	-99.72%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-	-
2023	-91.90%	-91.40%	-94.00%	0.08%	164.00%	180.00%	-54.29%	-88.29%	-57.14%	7.27%	7.27%	29.09%
2022	-67.87%	-78.71%	-77.51%	80.79%	100.00%	5.26%	7.33%	-13.33%	24.67%	0.00%	-68.50%	-91.94%
2021	-	-	-	-	-	-	-	-	-	20.34%	0.00%	-35.59%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31	2022-10-31	2022-07-31	2022-04-30	2022-01-31	2021-10-31	2021-07-31	2021-04-30	2021-01-31
Liquidity Ratios
Current Ratio	-	-	-	0.05	0.10	0.14	0.15	0.20	0.65	1.29	5.77	4.56	-
Quick Ratio	-	-	-	0.05	0.10	0.14	0.14	0.18	0.63	1.18	5.67	4.49	-
Working Capital	-	-	-	-1.74M	-1.41M	-1.34M	-1.44M	-1.16M	-523.78K	73.24K	1.22M	1.72M	-
Leverage & Debt
Debt to Equity	-	-	-	0.83	0.59	0.51	0.54	0.41	0.39	0.07	0.05	0.21	-
Interest Coverage TTM	-29.30	-30.53	-32.31	-24.89	-41.33	-55.53	-114.43	-4,291.72	-47.94	-25.18	-12.24	-8.10	-1.91
Debt Ratio	-	-	-	0.44	0.36	0.33	0.35	0.29	0.28	0.06	0.05	0.17	-
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Receivables Turnover TTM	0.00	-	-	-	-	-	-	-	-	-	-	-	-
Per Share Metrics
Diluted EPS TTM	-0.00	-	-	-	-0.00	-	-	-	-	-0.00	-	-	-0.00
Free Cash Flow Per Share TTM	-0.59	-0.00	-0.00	-0.00	-0.54	-0.00	-0.00	-0.00	-0.01	-4.13	-0.00	-0.00	-0.20
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-	-	-	-207,453.90%	-142,382.97%	-127,903.10%	-28,782.45%
Net Profit Margin TTM	-	-	-	-	-	-	-	-	-	-42,994.70%	39,264.64%	0.00%	-50,257.65%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-	-	-	-
Net Income Growth (1Y)	11.66%	-39.31%	-65.86%	-45.87%	42.19%	173.79%	-561.97%	-	47.46%	-35.17%	-143.37%	-100.00%	-30.77%
EPS Growth (1Y)	11.61%	-54.21%	-74.09%	-58.63%	89,141.82%	-99.67%	-520.71%	-	-99.80%	-44.99%	-135.80%	-100.00%	-40.82%
Valuation Metrics
P/E TTM	-0.00	-56.57	-38.68	-414.08	-0.25	-83.48	-873.19	-1,284.73	-4,828.90	-6.34	4,791.62	-	-3.41
P/B TTM	0.00	61.01	29.43	348.85	0.23	74.81	1,170.63	1,231.84	2,137.61	1.38	706.66	3,215.11	-1.72
P/S TTM	-	-	-	-	-	-	-	-	-	2,725.62	1,881,412.46	3,682,000.32	1,715.77
Market Cap	185.66	93.72M	55.54M	771.54M	612.44K	227.88M	3.67B	4.42B	8.30B	6.32M	4.36B	8.54B	3.98M
Enterprise Value	53.79K	93.68M	55.34M	771.51M	562.38K	227.80M	3.67B	4.42B	8.30B	6.14M	4.36B	8.54B	4.76M
Calculated Values
Free Cash Flow TTM	-1.10M	-1.09M	-833.70K	-879.21K	-995.76K	-1.02M	-3.78M	-4.08M	-6.79M	-6.53M	-3.87M	-3.19M	-316.81K
Net Debt	53.61K	-39.98K	-200.27K	-25.84K	-50.06K	-77.67K	99.09K	-141.21K	-711.13K	-184.76K	-1.32M	-2.07M	779.27K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-10-03Purchase

Owner: Cox, Scott

Title: CEO

Shares: 6,099,995

Price/Share: $0.00

Value: -

Shares Owned: 16,519,780

Relationship: Director,Officer

Ownership: Direct

2023-04-27Purchase

Owner: Cox, Scott

Title: Chief Executive Officer

Shares: 50,000

Price/Share: $0.00

Value: -

Shares Owned: 10,685,231

Relationship: Director,Officer

Ownership: Direct

2023-04-20Purchase

Owner: Cox, Scott

Title: Chief Executive Officer

Shares: 700,000

Price/Share: $0.00

Value: -

Shares Owned: 10,535,231

Relationship: Director,Officer

Ownership: Direct

2023-02-21Purchase

Owner: Cox, Scott

Title: Chief Executive Officer

Shares: 15,000

Price/Share: $0.00

Value: -

Shares Owned: 9,335,231

Relationship: Director,Officer

Ownership: Direct

2023-02-17Purchase

Owner: Cox, Scott

Title: Chief Executive Officer

Shares: 155,000

Price/Share: $0.00

Value: -

Shares Owned: 9,335,231

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-10-03	Cox, Scott	Director,Officer	CEO	Direct	Purchase	6,099,995	0.00	$0.00	16,519,780	4
2023-04-27	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	50,000	0.00	$0.00	10,685,231	4
2023-04-20	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	700,000	0.00	$0.00	10,535,231	4
2023-02-21	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	15,000	0.00	$0.00	9,335,231	4
2023-02-17	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	155,000	0.00	$0.00	9,335,231	4
2023-02-16	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	900,000	0.00	$0.00	8,691,231	4
2023-01-26	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	36,369	0.00	$0.00	7,071,314	4
2022-12-30	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	1,239,261	0.00	$0.00	6,644,781	4
2022-10-26	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	236,577	0.00	$0.00	5,143,580	4
2022-10-19	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	100	0.00	$0.00	4,880,523	4
2022-10-10	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	217,000	0.00	$0.00	4,433,642	4
2022-10-03	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	360,476	0.00	$0.00	3,978,547	4
2022-09-30	Cox, Scott	Director,Officer	Chief Executive Officer	Direct	Purchase	619,521	0.00	$0.00	3,978,547	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

No institutional ownership data available.

VERDE BIO HOLDINGS, INC. (APHD) — SEC Financial Statements & Analysis

VERDE BIO HOLDINGS, INC. (APHD) is a crude petroleum & natural gas company, incorporated in NV. VERDE BIO HOLDINGS, INC. trades on OTC as: APHD. Based on its latest SEC filing (Form 10-Q, period ending 2024-01-31), VERDE BIO HOLDINGS, INC. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.83x, a Price-to-Sales (P/S) ratio of 2725.62x (TTM), a Price-to-Book (P/B) ratio of 0 (TTM), at a market cap of $185.66. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 0.83x
P/S TTM: 2725.62x
P/B TTM: 0
Market Cap: $185.66

Data as of 2024-01-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is VERDE BIO HOLDINGS, INC. in?

VERDE BIO HOLDINGS, INC. (APHD) operates in the Crude Petroleum & Natural Gas industry.

What is APHD's market cap?

VERDE BIO HOLDINGS, INC. (APHD) has a market capitalization of $185.66 as of 2024-01-31.

What exchange does APHD trade on?

VERDE BIO HOLDINGS, INC. (APHD) trades on the OTC.

Where is VERDE BIO HOLDINGS, INC. incorporated?

VERDE BIO HOLDINGS, INC. is incorporated in NV.

VERDE BIO HOLDINGS, INC. (APHD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.